Formal Thought Disorder and language impairment in schizophrenia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 23249974)

Published in Arq Neuropsiquiatr on December 18, 2012

Authors

Marcia Radanovic1, Rafael T de Sousa, L Valiengo, Wagner Farid Gattaz, Orestes Vicente Forlenza

Author Affiliations

1: Laboratory of Neuroscience, Department and Institute of Psychiatry, Medical School, Universidade de São Paulo, Brazil. marciaradanovic@gmail.com

Articles citing this

The shape of the human language-ready brain. Front Psychol (2014) 1.10

Articles by these authors

Mental disorders in megacities: findings from the São Paulo megacity mental health survey, Brazil. PLoS One (2012) 1.56

Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Int J Neuropsychopharmacol (2006) 1.20

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry (2008) 1.17

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry (2010) 1.12

Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10

Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. Eur Arch Psychiatry Clin Neurosci (2008) 1.03

The detection of depression in medical setting: a study with PRIME-MD. J Affect Disord (2006) 1.00

The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Brief Funct Genomic Proteomic (2007) 0.97

Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr (2008) 0.97

Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc (2010) 0.96

White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies. Expert Rev Neurother (2013) 0.96

Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95

Recognition of depressive symptoms by physicians. Clinics (Sao Paulo) (2009) 0.93

Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. J Psychiatr Res (2010) 0.91

Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry (2010) 0.91

Use of psychoactive substances and sexual risk behavior in adolescents. Subst Use Misuse (2002) 0.88

Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis (2010) 0.88

Physical exercise in MCI elderly promotes reduction of pro-inflammatory cytokines and improvements on cognition and BDNF peripheral levels. Curr Alzheimer Res (2014) 0.87

The more information, the more negative stigma towards schizophrenia: Brazilian general population and psychiatrists compared. Psychiatry Res (2012) 0.86

Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement Geriatr Cogn Disord (2009) 0.86

Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry (2010) 0.85

Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr (2009) 0.85

Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education. Int Psychogeriatr (2009) 0.84

31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res (2002) 0.84

Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. Int J Geriatr Psychiatry (2011) 0.84

To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2009) 0.83

Vocational rehabilitation improves cognition and negative symptoms in schizophrenia. Schizophr Res (2010) 0.83

Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. Arch Clin Neuropsychol (2010) 0.83

Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol. CNS Spectr (2009) 0.82

Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment. Eur Arch Psychiatry Clin Neurosci (2014) 0.82

Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? World J Biol Psychiatry (2011) 0.81

Language impairment in euthymic, elderly patients with bipolar disorder but no dementia. Int Psychogeriatr (2008) 0.81

Stigma toward schizophrenia: do all psychiatrists behave the same? Latent profile analysis of a national sample of psychiatrists in Brazil. BMC Psychiatry (2013) 0.81

Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil. Rev Bras Psiquiatr (2008) 0.80

SHORT COMMUNICATION: Apolipoprotein E genotype and cognition in bipolar disorder. CNS Neurosci Ther (2010) 0.80

COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. J Affect Disord (2012) 0.79

Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. Clin Ther (2010) 0.79

Long-term decrease in immediate early gene expression after electroconvulsive seizures. J Neural Transm (Vienna) (2012) 0.78

Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil. Int Psychogeriatr (2010) 0.78

Allelic association analysis of phospholipase A2 genes with schizophrenia. Psychiatr Genet (2004) 0.78

Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients. Bipolar Disord (2014) 0.77

Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. Neuromolecular Med (2015) 0.77

Functional mobility in a divided attention task in older adults with cognitive impairment. J Mot Behav (2015) 0.77

Cognitive-linguistic deficits in euthymic elderly patients with bipolar disorder. J Affect Disord (2013) 0.77

Fear of falling and falls in older adults with mild cognitive impairment and Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2014) 0.77

The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia. Int Psychogeriatr (2013) 0.76

Higher proportion of inactive Gsk3β in platelets of elderly patients with bipolar disorder: an effect of treatment? Rev Bras Psiquiatr (2013) 0.76

Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia. Schizophr Res (2013) 0.76

Correction: The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects. PLoS One (2015) 0.75

Mental healthcare in South America with a focus on Brazil: past, present, and future. Curr Opin Psychiatry (2016) 0.75

Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. J Alzheimers Dis (2016) 0.75

Glycogen Synthase Kinase-3β: Variation over Time and the Possible Association with Mood and Cognition in Healthy Individuals. Neuropsychobiology (2016) 0.75

[Biologic artifacts in quantitative EEG]. Arq Neuropsiquiatr (2006) 0.75